3,6-Dichloro-4-iodopyridazine

Catalog No.: 
ACIRSD163
CAS No.: 
130825-13-7
Molecular Formula: 
C4HCl2IN2
Molecular Weight: 
274.88
3,6-Dichloro-4-iodopyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$160.00In stockInquiry
1g98%$403.00In stockInquiry
5g98%$980.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6-Dichloro-4-iodopyridazine
IUPAC Name3,6-dichloro-4-iodopyridazine
MDL No.MFCD18249972
Molecular FormulaC4HCl2IN2
Molecular Weight274.88
SMILESIC1=CC(Cl)=NN=C1Cl
InChI KeyDOZGQZSLDJZZMV-UHFFFAOYSA-N
Synonym3,6-Dichloro-4-iodopyridazine;oro-4-iodopyridazine;Pyridazine, 3,6-dichloro-4-iodo-;3,6-Dichloro-4-iodopyridazine ISO 9001:2015 REACH
CAS No.130825-13-7
PubChem CID11311884

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIRSD163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNROZ260 route compound structure diagram
    ACNROZ260141-30-0In Stock
  2. Then
  3. ACIRSD163 route product structure diagram
    ACIRSD163130825-13-7In Stock
Inquiry

2. ACIRSD163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  2. Plus
  3. ACIRSD163 route compound structure diagram
    ACIRSD163130825-13-7In Stock
  4. Then
  5. ACIRSD163 route product structure diagram
    ACIRSD163130825-13-7In Stock
Inquiry

3. ACIRSD163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSQID159 route compound structure diagram
    ACSQID1596082-66-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRSD163 route product structure diagram
    ACIRSD163130825-13-7In Stock
Inquiry

Comments (0)